Gene: SORD
Official Full Name: sorbitol dehydrogenaseprovided by HGNC
Gene Summary: Sorbitol dehydrogenase (SORD; EC 1.1.1.14) catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase (ALDR1; MIM 103880), makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications (summarized by Carr and Markham, 1995 [PubMed 8535074]). The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor.[supplied by OMIM, Jul 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35301 | SORD Knockout cell line (HeLa) | Human | SORD | 1:3~1:6 | Negative | Online Inquiry |
KO35302 | SORD Knockout cell line (HCT 116) | Human | SORD | 1:2~1:4 | Negative | Online Inquiry |
KO35303 | SORD Knockout cell line (HEK293) | Human | SORD | 1:3~1:6 | Negative | Online Inquiry |
KO35304 | SORD Knockout cell line (A549) | Human | SORD | 1:3~1:4 | Negative | Online Inquiry |
SORD Gene Knockout Cell Lines represent a powerful tool in genetic research, specifically engineered to silence the SORD gene, which encodes the enzyme sorbitol dehydrogenase. These cell lines are invaluable for investigating the physiological roles of the SORD gene, studying its implications in metabolic disorders, and elucidating pathways involved in diabetic complications and other disease states. By utilizing CRISPR-Cas9 or similar gene-editing technologies, our SORD gene knockout lines allow researchers to achieve specific and efficient gene disruption, providing a precise model to study the absence of SORD function in a controlled environment.
The primary function of these cell lines is to facilitate mechanistic studies that link SORD modulation to cellular metabolism, particularly in relation to the polyol pathway, where sorbitol is converted to fructose. Inhibition of this pathway is crucial for understanding conditions like neuropathy and retinopathy in diabetes, making SORD knockout lines essential for both basic and translational research.
From a scientific perspective, these cell lines offer significant advantages in clarity and specificity when compared to traditional methods such as chemical inhibitors or non-specific RNAi approaches. The irreversible gene editing ensures a stable knockout phenotype, reducing variability and enhancing reproducibility in experiments. Furthermore, these lines are suited for various applications, including drug screening, genetic interaction studies, and the development of therapeutic strategies against metabolic diseases.
For researchers and clinicians, utilizing SORD Gene Knockout Cell Lines presents a distinct opportunity to accelerate the understanding of SORD's role in disease pathology. Our commitment to quality and precision in our offerings stems from our extensive experience in genetic modeling and cell line development, ensuring that our products provide reliable results and contribute to advancing scientific knowledge and innovation in clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.